<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>UNITED
STATES SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B><BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;13 or 15(d)
of the</B><BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Date of Report (Date of Earliest Event
Reported): October 18, 2012</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MusclePharm Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in
Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; font-weight: bold; text-align: center">Nevada</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; font-weight: bold; text-align: center">000-53166</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 31%; font-weight: bold; text-align: center">77-0664193</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">(State or Other Jurisdiction<BR> of Incorporation)</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">(Commission File Number)</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">(IRS Employer Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4721 Ironton Street, Building A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Denver, Colorado 80239</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;(Address of Principal Executive Offices)<BR>
<BR></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(303) 396-6100</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;(Registrant&rsquo;s Telephone Number,
Including Area Code)<BR>
<BR></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address if Changed
Since Last Report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(<I>see </I>General Instruction A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;</FONT>
Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;</FONT>
Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;</FONT>
Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;</FONT>
Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On October 18, 2012, the Compensation Committee (the &ldquo;Committee&rdquo;)
of the Board of Directors (the &ldquo;Board&rdquo;) of MusclePharm Corporation (the &ldquo;Company&rdquo;) approved 2012 target
bonuses for its executive officers, including its principal executive officer, principal financial officer and other named executive
officers as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">Executive Officer</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2012 Target Bonuses (gross)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="width: 79%; text-align: left">Brad J. Pyatt</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">160,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">John H. Bluher</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">130,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left">Cory J. Gregory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">130,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Jeremy R. DeLuca</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">130,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: left">L. Gary Davis</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Also, on October 18, 2012, the Company entered into amended
and restated employment agreements (except for Mr. Davis, which was an initial employment agreement) (collectively, the &ldquo;Employment
Agreements&rdquo;) with the following executive officers of the Company (collectively, the &ldquo;Officers&rdquo;), which include
its principal executive officer, principal financial officer and other named executive officers:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 21%; border-bottom: windowtext 1pt solid; font-weight: bold">Name</TD>
    <TD STYLE="width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 77%; border-bottom: windowtext 1pt solid; font-weight: bold">Position</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Brad J. Pyatt</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer and President</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>L. Gary Davis</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Financial Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>John H. Bluher</TD>
    <TD>&nbsp;</TD>
    <TD>Executive Vice President &ndash; Chief Operating Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Jeremy R. DeLuca</TD>
    <TD>&nbsp;</TD>
    <TD>Executive Vice President &ndash; Chief Marketing Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Cory J. Gregory</TD>
    <TD>&nbsp;</TD>
    <TD>Executive Vice President</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Employment Agreements were executed based upon a form employment
agreement approved by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Employment Agreements are for an initial term ending December
31, 2014. However, the Employment Agreements entered into with Mr. Pyatt and Mr. DeLuca provide for an initial term ending December
31, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the terms of the Employment Agreements, each Officer will
receive an annual base salary in the amount set forth below, subject to any increase the Compensation Committee may deem appropriate
from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; border-bottom: windowtext 1pt solid; font-weight: bold">Name</TD>
    <TD STYLE="width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 63%; border-bottom: windowtext 1pt solid; font-weight: bold">Annual Base Salary</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD>Brad J. Pyatt</TD>
    <TD>&nbsp;</TD>
    <TD>$350,000</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>L. Gary Davis</TD>
    <TD>&nbsp;</TD>
    <TD>$130,000 ($200,000 beginning January 1, 2013)</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD>John H. Bluher</TD>
    <TD>&nbsp;</TD>
    <TD>$300,000</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>Jeremy R. DeLuca</TD>
    <TD>&nbsp;</TD>
    <TD>$175,000 ($320,000 beginning January 1, 2013)</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD>Cory J. Gregory</TD>
    <TD>&nbsp;</TD>
    <TD>$212,000</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, the Officers will be eligible to receive one or
more annual cash bonuses and grants of stock options, restricted stock or other equity-related awards from the Company&rsquo;s
various equity compensation plans, as determined by the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the Company&rsquo;s employment of an Officer terminates due
to the Officer&rsquo;s death or inability to perform, the Employment Agreements provide for payment to the Officer of any unpaid
portion of the Officer&rsquo;s base salary and benefits accrued through the date of death or inability to perform and, at the discretion
of the Compensation Committee, a bonus. The Officer or his representatives will also be entitled to receive a reimbursement of
up to 12 months of Consolidated Omnibus Reconciliation Act, or COBRA, premiums, if the Officer or his representatives timely elect
and remain eligible for COBRA. If the Officer&rsquo;s employment is terminated due to inability to perform, the Officer will also
be entitled to (i) a lump sum payment equal to the greater of (A)&nbsp;the target bonus payable to the Officer for the year in
which the date of termination occurs or if no target bonus has been set, the Officer&rsquo;s most recent annual bonus, and (B)
a bonus for such year as may be determined by the Compensation Committee in its sole discretion; and (ii) a severance payment (payable
over six months) equal to six months of the Officer&rsquo;s base salary in effect as of the date of termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the Officer&rsquo;s employment is terminated for &ldquo;cause&rdquo;
or if an Officer terminates his employment without &ldquo;good reason&rdquo; (as such terms are defined in the Employment Agreement),
the Officer will not be entitled to a severance payment or any other termination benefits. However, the Company will pay the Officer
any unpaid portion of the Officer&rsquo;s base salary and benefits accrued through the date of such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon a termination of an Officer&rsquo;s employment (except
for Mr. Pyatt) by the Company without cause and without a change in control or by the Officer for good reason without a change
in control, the Employment Agreements provide that such Officer will be entitled to (i) any unpaid portion of the Officer&rsquo;s
base salary and benefits accrued through the date of termination; (ii) an amount payable over three months and equal to the lesser
of (A) nine months of the Officer&rsquo;s base salary in effect as of the date of termination, or (B) the Officer&rsquo;s base
salary remaining under the term of his Employment Agreement; (iii) a lump sum payment equal to 25% of the Officer&rsquo;s target
bonus (or if no target bonus has been set, the Officer&rsquo;s most recent annual bonus) if the termination is between January
1 and June 30 or 50% of the Officer&rsquo;s target bonus (or if no target bonus has been set, the Officer&rsquo;s most recent annual
bonus) if the termination is between July 1 and December 31; (iv)&nbsp;acceleration of the Officer&rsquo;s outstanding equity awards,
unless otherwise provided in the equity award agreement for a particular equity award; and (v) the Officer will also be entitled
to receive a reimbursement of up to 12 months of COBRA premiums, if the Officer timely elects and remains eligible for COBRA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon a termination of Mr. Pyatt&rsquo;s employment by the Company
without cause and without a change in control or by Mr. Pyatt for good reason without a change in control, Mr. Pyatt&rsquo;s Employment
Agreement provides that he will be entitled to (i) any unpaid portion of his base salary and benefits accrued through the date
of termination; (ii) an amount payable over three months and equal to two times his base salary on the date of termination; (iii)
a lump sum payment equal to the greater of (A) two times his target bonus for the for the year in which the date of termination
occurs or if no target bonus has been set, then two times Mr. Pyatt&rsquo;s most recent annual bonus, and (B) a bonus for such
year as may be determined by the Compensation Committee in its sole discretion; (iv)&nbsp;acceleration of his outstanding equity
awards, unless otherwise provided in the equity award agreement for a particular equity award; and (v) he will also be entitled
to receive a reimbursement of up to 12 months of COBRA premiums, if he timely elects and remains eligible for COBRA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon a termination of an Officer&rsquo;s employment (except
for Mr. Pyatt) by the Company without cause and with a change in control or by the Officer for good reason after a change in control,
the Employment Agreements provide that such Officer will be entitled to (i) any unpaid portion of the Officer&rsquo;s base salary
and benefits accrued through the date of termination; (ii) a severance payment (payable over 12 months) equal to 12 months of the
Officer&rsquo;s base salary in effect as of the date of termination; (iii) a lump sum payment equal to the greater of (A) 100%
of the Officer&rsquo;s target bonus in the year of termination or if no target bonus has been set, then 100% of the Officer&rsquo;s
most recent annual bonus, and (B) a bonus for such year as may be determined by the Committee in its sole discretion; (iv)&nbsp;a
severance payment of $500,000 (payable within 30 days of the date of termination); (v) acceleration of the Officer&rsquo;s outstanding
equity awards; and (vi) the Officer will also be entitled to receive a reimbursement of up to 12 months of COBRA premiums, if the
Officer timely elects and remains eligible for COBRA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon a termination of Mr. Pyatt&rsquo;s Employment Agreement
by the Company without cause and with a change in control or by Mr. Pyatt for good reason after a change in control, Mr. Pyatt&rsquo;s
Employment Agreement provides that he will be entitled to (i) any unpaid portion of his base salary and benefits accrued through
the date of termination; (ii) a severance payment (payable over 12 months) equal to three times his base salary in effect as of
the date of termination; (iii)&nbsp;a severance payment of $2 million (payable within 30 days of the date of termination); (v)
acceleration of the Officer&rsquo;s outstanding equity awards; and (vi) he will also be entitled to receive a reimbursement of
up to 12 months of COBRA premiums, if he timely elects and remains eligible for COBRA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Employment Agreements also contain customary confidentiality,
non-competition and non-solicitation provisions. Under the non-compete provisions, during the term of his Employment Agreement
and for a period of six months after termination of employment, the Officer is prohibited from, directly or indirectly, engaging
in or becoming interested financially in, as a principal, employee, partner, contractor, shareholder, agent, manager, owner, advisor,
lender, guarantor, officer or director, any business that is engaged in the nutritional supplement industry and/or related products,
subject to certain exceptions for passive investments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additionally, the non-solicitation provisions of the Employment
Agreements prohibit the Officer from soliciting for employment any employee of the Company or any person who was an employee of
the Company in the 90-day period before such solicitation. This prohibition applies during the Officer&rsquo;s employment with
the Company and for 12 months following the termination of the Officer&rsquo;s employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing descriptions are not complete and are qualified
in their entirety by reference to the full text of the Employment Agreements, copies of which are attached as Exhibits 10.1, 10.2,
10.3, 10.4 and 10.5 to this Current Report on Form 8-K and are hereby incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 9.01. Financial Statements and Exhibits. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">(d)</TD>
    <TD STYLE="width: 95%">Exhibits:</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 95%">The following exhibits are filed with this Current Report on Form 8-K:</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 12%; border-bottom: windowtext 1pt solid; font-weight: bold">Exhibit No.</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 81%; border-bottom: windowtext 1pt solid; font-weight: bold; text-align: center">Description</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10.1</TD>
    <TD>&nbsp;</TD>
    <TD>Amended and Restated Employment Agreement, dated October 18, 2012, between MusclePharm Corporation and Brad J. Pyatt.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10.2</TD>
    <TD>&nbsp;</TD>
    <TD>Employment Agreement, dated October 18, 2012, between MusclePharm Corporation and L. Gary Davis.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10.3</TD>
    <TD>&nbsp;</TD>
    <TD>Amended and Restated Employment Agreement, dated October 18, 2012, between MusclePharm Corporation and John H. Bluher.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10.4</TD>
    <TD>&nbsp;</TD>
    <TD>Amended and Restated Employment Agreement, dated October 18, 2012, between MusclePharm Corporation and Jeremy R. DeLuca.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10.5</TD>
    <TD>&nbsp;</TD>
    <TD>Amended and Restated Employment Agreement, dated October 18, 2012, between MusclePharm Corporation and Cory J. Gregory.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: justify">MUSCLEPHARM CORPORATION</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Dated: October 24, 2012</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">By:</TD>
    <TD STYLE="border-bottom: windowtext 1pt solid; text-align: justify">/s/ Brad J. Pyatt</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="text-align: justify">Brad J. Pyatt</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">Chief Executive Officer and President</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v326604_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 30487}]
{"company-data": {"conformed-name": "MusclePharm Corp", "cik": "0001415684", "assigned-sic": "2834", "irs-number": "770664193", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-53166", "film-number": "121159282"}, "business-address": {"street1": "4721 IRONTON STREET", "city": "DENVER", "state": "CO", "zip": "80239", "phone": "(800) 210-7369"}, "mail-address": {"street1": "4721 IRONTON STREET", "city": "DENVER", "state": "CO", "zip": "80239"}, "former-company": {"former-conformed-name": "Tone in Twenty", "date-changed": "20071018"}}
UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event
Reported): October 18, 2012
MusclePharm Corporation
(Exact Name of Registrant as Specified in
Charter)
Nevada
000-53166
77-0664193
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
4721 Ironton Street, Building A
Denver, Colorado 80239
(Address of Principal Executive Offices)
(303) 396-6100
(Registrant's Telephone Number,
Including Area Code)
N/A
(Former Name or Former Address if Changed
Since Last Report)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(
see
General Instruction A.2. below):
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c)).
ITEM 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 18, 2012, the Compensation Committee (the "Committee")
of the Board of Directors (the "Board") of MusclePharm Corporation (the "Company") approved 2012 target
bonuses for its executive officers, including its principal executive officer, principal financial officer and other named executive
officers as follows:
Executive Officer
2012 Target Bonuses (gross)
Brad J. Pyatt
$
160,000
John H. Bluher
$
130,000
Cory J. Gregory
$
130,000
Jeremy R. DeLuca
$
130,000
L. Gary Davis
$
75,000
Also, on October 18, 2012, the Company entered into amended
and restated employment agreements (except for Mr. Davis, which was an initial employment agreement) (collectively, the "Employment
Agreements") with the following executive officers of the Company (collectively, the "Officers"), which include
its principal executive officer, principal financial officer and other named executive officers:
Name
Position
Brad J. Pyatt
Chief Executive Officer and President
L. Gary Davis
Chief Financial Officer
John H. Bluher
Executive Vice President – Chief Operating Officer
Jeremy R. DeLuca
Executive Vice President – Chief Marketing Officer
Cory J. Gregory
Executive Vice President
The Employment Agreements were executed based upon a form employment
agreement approved by the Committee.
The Employment Agreements are for an initial term ending December
31, 2014. However, the Employment Agreements entered into with Mr. Pyatt and Mr. DeLuca provide for an initial term ending December
31, 2015.
Under the terms of the Employment Agreements, each Officer will
receive an annual base salary in the amount set forth below, subject to any increase the Compensation Committee may deem appropriate
from time to time.
Name
Annual Base Salary
Brad J. Pyatt
$350,000
L. Gary Davis
$130,000 ($200,000 beginning January 1, 2013)
John H. Bluher
$300,000
Jeremy R. DeLuca
$175,000 ($320,000 beginning January 1, 2013)
Cory J. Gregory
$212,000
In addition, the Officers will be eligible to receive one or
more annual cash bonuses and grants of stock options, restricted stock or other equity-related awards from the Company's
various equity compensation plans, as determined by the Compensation Committee.
If the Company's employment of an Officer terminates due
to the Officer's death or inability to perform, the Employment Agreements provide for payment to the Officer of any unpaid
portion of the Officer's base salary and benefits accrued through the date of death or inability to perform and, at the discretion
of the Compensation Committee, a bonus. The Officer or his representatives will also be entitled to receive a reimbursement of
up to 12 months of Consolidated Omnibus Reconciliation Act, or COBRA, premiums, if the Officer or his representatives timely elect
and remain eligible for COBRA. If the Officer's employment is terminated due to inability to perform, the Officer will also
be entitled to (i) a lump sum payment equal to the greater of (A) the target bonus payable to the Officer for the year in
which the date of termination occurs or if no target bonus has been set, the Officer's most recent annual bonus, and (B)
a bonus for such year as may be determined by the Compensation Committee in its sole discretion; and (ii) a severance payment (payable
over six months) equal to six months of the Officer's base salary in effect as of the date of termination.
If the Officer's employment is terminated for "cause"
or if an Officer terminates his employment without "good reason" (as such terms are defined in the Employment Agreement),
the Officer will not be entitled to a severance payment or any other termination benefits. However, the Company will pay the Officer
any unpaid portion of the Officer's base salary and benefits accrued through the date of such termination.
Upon a termination of an Officer's employment (except
for Mr. Pyatt) by the Company without cause and without a change in control or by the Officer for good reason without a change
in control, the Employment Agreements provide that such Officer will be entitled to (i) any unpaid portion of the Officer's
base salary and benefits accrued through the date of termination; (ii) an amount payable over three months and equal to the lesser
of (A) nine months of the Officer's base salary in effect as of the date of termination, or (B) the Officer's base
salary remaining under the term of his Employment Agreement; (iii) a lump sum payment equal to 25% of the Officer's target
bonus (or if no target bonus has been set, the Officer's most recent annual bonus) if the termination is between January
1 and June 30 or 50% of the Officer's target bonus (or if no target bonus has been set, the Officer's most recent annual
bonus) if the termination is between July 1 and December 31; (iv) acceleration of the Officer's outstanding equity awards,
unless otherwise provided in the equity award agreement for a particular equity award; and (v) the Officer will also be entitled
to receive a reimbursement of up to 12 months of COBRA premiums, if the Officer timely elects and remains eligible for COBRA.
Upon a termination of Mr. Pyatt's employment by the Company
without cause and without a change in control or by Mr. Pyatt for good reason without a change in control, Mr. Pyatt's Employment
Agreement provides that he will be entitled to (i) any unpaid portion of his base salary and benefits accrued through the date
of termination; (ii) an amount payable over three months and equal to two times his base salary on the date of termination; (iii)
a lump sum payment equal to the greater of (A) two times his target bonus for the for the year in which the date of termination
occurs or if no target bonus has been set, then two times Mr. Pyatt's most recent annual bonus, and (B) a bonus for such
year as may be determined by the Compensation Committee in its sole discretion; (iv) acceleration of his outstanding equity
awards, unless otherwise provided in the equity award agreement for a particular equity award; and (v) he will also be entitled
to receive a reimbursement of up to 12 months of COBRA premiums, if he timely elects and remains eligible for COBRA.
Upon a termination of an Officer's employment (except
for Mr. Pyatt) by the Company without cause and with a change in control or by the Officer for good reason after a change in control,
the Employment Agreements provide that such Officer will be entitled to (i) any unpaid portion of the Officer's base salary
and benefits accrued through the date of termination; (ii) a severance payment (payable over 12 months) equal to 12 months of the
Officer's base salary in effect as of the date of termination; (iii) a lump sum payment equal to the greater of (A) 100%
of the Officer's target bonus in the year of termination or if no target bonus has been set, then 100% of the Officer's
most recent annual bonus, and (B) a bonus for such year as may be determined by the Committee in its sole discretion; (iv) a
severance payment of $500,000 (payable within 30 days of the date of termination); (v) acceleration of the Officer's outstanding
equity awards; and (vi) the Officer will also be entitled to receive a reimbursement of up to 12 months of COBRA premiums, if the
Officer timely elects and remains eligible for COBRA.
Upon a termination of Mr. Pyatt's Employment Agreement
by the Company without cause and with a change in control or by Mr. Pyatt for good reason after a change in control, Mr. Pyatt's
Employment Agreement provides that he will be entitled to (i) any unpaid portion of his base salary and benefits accrued through
the date of termination; (ii) a severance payment (payable over 12 months) equal to three times his base salary in effect as of
the date of termination; (iii) a severance payment of $2 million (payable within 30 days of the date of termination); (v)
acceleration of the Officer's outstanding equity awards; and (vi) he will also be entitled to receive a reimbursement of
up to 12 months of COBRA premiums, if he timely elects and remains eligible for COBRA.
The Employment Agreements also contain customary confidentiality,
non-competition and non-solicitation provisions. Under the non-compete provisions, during the term of his Employment Agreement
and for a period of six months after termination of employment, the Officer is prohibited from, directly or indirectly, engaging
in or becoming interested financially in, as a principal, employee, partner, contractor, shareholder, agent, manager, owner, advisor,
lender, guarantor, officer or director, any business that is engaged in the nutritional supplement industry and/or related products,
subject to certain exceptions for passive investments.
Additionally, the non-solicitation provisions of the Employment
Agreements prohibit the Officer from soliciting for employment any employee of the Company or any person who was an employee of
the Company in the 90-day period before such solicitation. This prohibition applies during the Officer's employment with
the Company and for 12 months following the termination of the Officer's employment.
The foregoing descriptions are not complete and are qualified
in their entirety by reference to the full text of the Employment Agreements, copies of which are attached as Exhibits 10.1, 10.2,
10.3, 10.4 and 10.5 to this Current Report on Form 8-K and are hereby incorporated herein by reference.
ITEM 9.01. Financial Statements and Exhibits.
(d)
Exhibits:
The following exhibits are filed with this Current Report on Form 8-K:
Exhibit No.
Description
10.1
Amended and Restated Employment Agreement, dated October 18, 2012, between MusclePharm Corporation and Brad J. Pyatt.
10.2
Employment Agreement, dated October 18, 2012, between MusclePharm Corporation and L. Gary Davis.
10.3
Amended and Restated Employment Agreement, dated October 18, 2012, between MusclePharm Corporation and John H. Bluher.
10.4
Amended and Restated Employment Agreement, dated October 18, 2012, between MusclePharm Corporation and Jeremy R. DeLuca.
10.5
Amended and Restated Employment Agreement, dated October 18, 2012, between MusclePharm Corporation and Cory J. Gregory.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MUSCLEPHARM CORPORATION
Dated: October 24, 2012
By:
/s/ Brad J. Pyatt
Name:
Brad J. Pyatt
Title:
Chief Executive Officer and President